DRL launches Plermin for diabetic foot ulcers
Dr Reddy’s Laboratories (DRL) has launched Plermin - recombinant human Platelet Derived Growth Factor - rhPDGF- the first drug to be launched in India for the treatment of diabetic foot ulcers. The product will be available as a gel in 7.5 gm and 15 gm tubes.

Jubilant Organosys to acquire US pharma company
Jubilant Organosys Ltd, a composite pharmaceuticals industry player, has signed a Memorandum of Understanding (MoU) to acquire 75 per cent of the equity in a generic pharmaceutical company in the USA.